ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 177 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q4 2016. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $67,000,000 | -21.2% | 1,444,584 | -9.5% | 1.00% | -20.4% |
| Q3 2017 | $85,021,000 | +0.3% | 1,596,334 | +17.0% | 1.26% | +4.0% |
| Q2 2017 | $84,745,000 | +1.0% | 1,364,434 | +10.2% | 1.21% | +2.6% |
| Q1 2017 | $83,900,000 | +1.5% | 1,237,825 | +5.3% | 1.18% | +1.6% |
| Q4 2016 | $82,658,000 | -7.3% | 1,175,616 | -6.5% | 1.16% | -0.8% |
| Q3 2016 | $89,191,000 | +111.2% | 1,257,271 | +45.6% | 1.17% | +138.6% |
| Q2 2016 | $42,229,000 | -30.6% | 863,392 | -10.2% | 0.49% | -25.2% |
| Q1 2016 | $60,850,000 | -51.2% | 961,145 | -13.5% | 0.66% | -47.6% |
| Q4 2015 | $124,695,000 | +3.4% | 1,111,566 | -11.3% | 1.25% | +29.8% |
| Q3 2015 | $120,639,000 | -49.5% | 1,252,614 | -46.3% | 0.96% | -37.4% |
| Q2 2015 | $238,996,000 | +71.5% | 2,334,173 | +4.0% | 1.54% | +102.8% |
| Q1 2015 | $139,374,000 | +138.7% | 2,244,710 | +68.7% | 0.76% | +162.3% |
| Q4 2014 | $58,386,000 | -42.4% | 1,330,567 | -25.7% | 0.29% | -38.1% |
| Q3 2014 | $101,375,000 | +31.0% | 1,791,082 | -0.1% | 0.47% | +50.2% |
| Q2 2014 | $77,393,000 | -5.5% | 1,793,182 | -0.1% | 0.31% | -3.4% |
| Q1 2014 | $81,868,000 | – | 1,795,482 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| First Light Asset Management, LLC | 437,512 | $31,772,000 | 2.80% |
| RTW INVESTMENTS, LP | 1,373,284 | $99,728,000 | 2.06% |
| Rock Springs Capital Management LP | 1,028,109 | $74,661,000 | 1.88% |
| Privium Fund Management B.V. | 112,727 | $8,186,000 | 1.81% |
| Avidity Partners Management LP | 869,000 | $63,107,000 | 1.31% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 525,100 | $38,133,000 | 1.16% |
| Boxer Capital, LLC | 200,000 | $14,524,000 | 0.75% |
| SECTOR GAMMA AS | 46,221 | $3,357,000 | 0.73% |
| FEDERATED HERMES, INC. | 3,987,728 | $289,589,000 | 0.65% |
| EMERALD ADVISERS, LLC | 223,952 | $16,263,000 | 0.62% |